Page All:
Page 1
Midas Medici's CommodityPoint Announces New Guide on Commodity Trading & Risk Management Ancillary Software
Sourcebook Covers Over 30 Supplemental CTRM Products and Vendors
NEW YORK, Aug. 4, 2011 /PRNewswire/ -- Midas Medici Group Holdings, Inc. ("Midas") (OTCBB: MMED), an innovative green IT company in the fields of virtualization, cloud computing and data management, as well as Smart Grid solutions, today announced that its CommodityPoint brand, a leading provider of world-class research, analysis and consulting for global commodity markets, released The CommodityPoint Sourcebook - CTRM Ancillary Products Version 2. The guide provides detailed listings of over 30 Ancillary CTRM products and vendors.
"We are pleased to announce the latest version of Sourcebook through our CommodityPoint brand," stated Nana Baffour, CEO and Co-Founder of Midas Medici.
"In this second version, we anticipate an increased interest as a result of the addition of new software categories," said CommodityPoint Director of Business Development Mark Tredway. "Several more vendors have been included; this will provide better insight into the market, allowing prospective users to have a more effective tool in their search for ancillary CTRM products."
This latest component of the CommodityPoint Sourcebook Series focuses on products and software that, while ancillary to the core CTRM software used by commodity trading and risk management organizations, have become an increasingly critical part of the infrastructures necessary to compete in today's markets. Each listing provides graphical data, plus functionality and product install base information to help determine the best choices in supplemental CTRM software to support specific business needs.
The CommodityPoint Sourcebook - CTRM Ancillary Products is available as a free download from both the UtiliPoint website (http://www.utilipoint.com) and CTRM Blog (http://www.ctrmblog.com).
About Midas Medici Group Holdings, Inc.
Midas Medici Group Holdings, Inc. (OTCBB: MMED) is a green IT company that supplies mid-sized and select enterprises and institutions with leading-edge IT solutions in the fields of virtualization, cloud computing and data management, as well as working with utilities and other institutions to transform the electric grid through digital technologies. Across its Consonus and UtiliPoint brands, Midas works with its customers by optimizing IT and data center investments, cutting energy usage and preventing data loss, all while maximizing productivity. Through a management team with decades of experience, Midas is positioning itself to take advantage of the high-growth IT industry through its unique specialized services at the intersection of energy and technology.
For comprehensive investor relations material, including fact sheets, presentations conference calls and video, please follow the appropriate link: Investor Presentation, Investor Portal, Research Report and Overview Video.
For more information on Midas Medici, please visit: http://www.midasmedici.com.
Safe Harbor Statement
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding: the Company's business and operations; business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Company Contact:
Johnson Kachidza
Chief Financial Officer
212-792-0920
Investor Contact:
Trilogy Capital Partners
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com
SOURCE Midas Medici Group Holdings, Inc.
Midas Medici Group Holdings, Inc.
Web Site: http://www.midasmedici.com
Midas Medici's CommodityPoint Announces New Guide on Commodity Trading & Risk Management Ancillary Software
Sourcebook Covers Over 30 Supplemental CTRM Products and Vendors
NEW YORK, Aug. 4, 2011 /PRNewswire/ -- Midas Medici Group Holdings, Inc. ("Midas") (OTCBB: MMED), an innovative green IT company in the fields of virtualization, cloud computing and data management, as well as Smart Grid solutions, today announced that its CommodityPoint brand, a leading provider of world-class research, analysis and consulting for global commodity markets, released The CommodityPoint Sourcebook - CTRM Ancillary Products Version 2. The guide provides detailed listings of over 30 Ancillary CTRM products and vendors.
"We are pleased to announce the latest version of Sourcebook through our CommodityPoint brand," stated Nana Baffour, CEO and Co-Founder of Midas Medici.
"In this second version, we anticipate an increased interest as a result of the addition of new software categories," said CommodityPoint Director of Business Development Mark Tredway. "Several more vendors have been included; this will provide better insight into the market, allowing prospective users to have a more effective tool in their search for ancillary CTRM products."
This latest component of the CommodityPoint Sourcebook Series focuses on products and software that, while ancillary to the core CTRM software used by commodity trading and risk management organizations, have become an increasingly critical part of the infrastructures necessary to compete in today's markets. Each listing provides graphical data, plus functionality and product install base information to help determine the best choices in supplemental CTRM software to support specific business needs.
The CommodityPoint Sourcebook - CTRM Ancillary Products is available as a free download from both the UtiliPoint website (http://www.utilipoint.com) and CTRM Blog (http://www.ctrmblog.com).
About Midas Medici Group Holdings, Inc.
Midas Medici Group Holdings, Inc. (OTCBB: MMED) is a green IT company that supplies mid-sized and select enterprises and institutions with leading-edge IT solutions in the fields of virtualization, cloud computing and data management, as well as working with utilities and other institutions to transform the electric grid through digital technologies. Across its Consonus and UtiliPoint brands, Midas works with its customers by optimizing IT and data center investments, cutting energy usage and preventing data loss, all while maximizing productivity. Through a management team with decades of experience, Midas is positioning itself to take advantage of the high-growth IT industry through its unique specialized services at the intersection of energy and technology.
For comprehensive investor relations material, including fact sheets, presentations conference calls and video, please follow the appropriate link: Investor Presentation, Investor Portal, Research Report and Overview Video.
For more information on Midas Medici, please visit: http://www.midasmedici.com.
Safe Harbor Statement
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding: the Company's business and operations; business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Company Contact:
Johnson Kachidza
Chief Financial Officer
212-792-0920
Investor Contact:
Trilogy Capital Partners
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com
SOURCE Midas Medici Group Holdings, Inc.
Midas Medici Group Holdings, Inc.
Web Site: http://www.midasmedici.com